2024: Hunter Holthoff, M.D., Ph.D.
Insulin-like growth factor binding proteins in cisplatin-induced acute kidney injury
2023: KyoungHyun Kim, Ph.D.
Histone methylation in fatty liver disease-associated hepatocellular carcinoma
2023: Shelbie Stahr, Ph.D.
Heavy metal traces in saliva as markers of environmental exposure in breast cancer
2022: Michael Robeson, Ph.D.
Determining the role of probiotics in cognitive decline due to chemotherapeutics
2021: Samir Jenkins, Ph.D.
Photosensitizer-gold conjugates for X-ray induced photodynamic therapy of tumors
2021: Rajshekhar Kore, Ph.D.
MSC exosome mediated notch-1 signaling in radiation induced cardiac fibrosis repair
2019: Analiz Rodriguez, M.D., Ph.D.
Photobiomodulation of neuronal mitochondria treats radiation-induced cognitive dysfunction
2019: Amanda Stolarz, Pharm.D., Ph.D.
Mechanism by which doxorubicin contributes to lymphedema
2017: Brendan Frett, Ph.D.
Mitigating side effects of cancer therapy through Syk inhibition
2016: Antiño Allen, Ph.D.
Effects of methotrexate and cytosine arabinoside on cognition
2016: Nithin Karakala, M.D.
Identification of novel biomarkers in cisplatin induced acute kidney injury
2015: Allison Harrill, Ph.D.
miRNA biomarkers of cisplatin nephrotoxicity in genetically sensitive subjects
2015: Sharda Singh, Ph.D.
Attenuating doxorubicin cardiotoxicity with sulforaphane in patients with breast cancer